Skip to main content

Advertisement

SpringerLink
Log in

Pharmacological Treatment in Upper Gastrointestinal Bleeding

  • Stomach (C Howden, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Abstract

Acute upper gastrointestinal bleeding (AUGIB) is a common medical emergency. Bleeding peptic ulcers account for the majority of causes in patients presenting with AUGIB, whereas variceal bleeding in cirrhotic patients represents a more severe form of bleeding. Endoscopic therapy is the mainstay of treatment in patients with active bleeding, as it achieves hemostasis and improves patient outcomes. Pharmacotherapy is an important adjunct to endoscopic hemostasis. In the management of patients with bleeding peptic ulcers, acid suppression after endoscopic hemostasis reduces rates of further bleeding and interventions. In patients with stable hemodynamics awaiting endoscopy, acid suppression starts ulcer healing and downstages stigmata of bleeding, thereby reducing the need for endoscopic therapy. In managing patients with variceal bleeding, early administration of vasoactive drugs lowers splanchnic blood flow, promotes hemostasis, and makes subsequent endoscopic treatment easier. The use of vasoactive agents and antibiotics have both been shown to reduce mortality. In this review article, strategies of acid suppression therapy for peptic ulcer bleeds, vasoactive agents, and antibiotics for variceal bleeding, together with recent evidence on the use of tranexamic acid in gastrointestinal bleeding, are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnosis and outcomes in the 2007 UK audit. Gut. 2011;60:1327–35.

    Article  PubMed  Google Scholar 

  2. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7:33–47.

    Article  PubMed  Google Scholar 

  3. Green Jr FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74:38–43.

    CAS  PubMed  Google Scholar 

  4. Chaimoff C, Creter D, Djaldetti M. The effect of pH on platelet and coagulation factor activities. Am J Surg. 1978;136:257–9.

    Article  CAS  PubMed  Google Scholar 

  5. Patchett SE, Enright H, Afdhal N, O’Connell W, O’Donoghue DP. Clot lysis by gastric juice: an in vitro study. Gut. 1989;30:1704–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol. 1999;94:351–7.

    CAS  PubMed  Google Scholar 

  7. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997;336:1054–8.

    Article  CAS  PubMed  Google Scholar 

  8. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310–6.

    Article  CAS  PubMed  Google Scholar 

  9. Sung JJ, Barkun A, Kuipers EJ, Mössner J, Jensen DM, Stuart R, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009;150:455–64.

    Article  PubMed  Google Scholar 

  10. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2010;12, CD002094.

    Google Scholar 

  11. Neumann I, Letelier LM, Rada G, Ciaro JC, Martin J, Howden CW, et al. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2013;6, CD007999.

    PubMed  Google Scholar 

  12. Chan WH, Khin LW, Chung YF, Goh YC, Ong HS, Wong WK. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding. Br J Surg. 2011;98:640–4.

    Article  CAS  PubMed  Google Scholar 

  13. Sung JJ, Suen BY, Wu JC, Lau JY, Ching JY, Lee VW, et al. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. Am J Gastroenterol. 2014;109:1005–10.

    Article  CAS  PubMed  Google Scholar 

  14. Sachar H, Vaidya K, Laine L. Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(11):1755–62. This meta-analysis compared intermittent vs continuous PPI in peptic ulcer bleeding, and showed no difference in recurrent bleeding within 30 days, surgery or mortality.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Laine L, Shah A, Bernanian S. Intragastric pH with oral vs intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology. 2008;134:1836–41.

    Article  PubMed  Google Scholar 

  16. Lau JY, Leung WK, Wu JC, Chan FK, Wong VW, Chiu P, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. New Engl J Med. 2007;356:1631–40.

    Article  CAS  PubMed  Google Scholar 

  17. Sreedharan A, Martin J, Leontiadis GI, Dorward S, Howden CW, Forman D, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;7, CD005415. doi:10.1002/14651858.CD005415.pub3.

    PubMed  Google Scholar 

  18. Al-Sabah S, Barkun AN, Herba K, Adam V, Fallone C, Mayrand S, et al. Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2008;6:418–25.

    Article  PubMed  Google Scholar 

  19. Tsoi KK, Lau JY, Sung JJ. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointest Endosc. 2008;67(7):1056–63.

    Article  PubMed  Google Scholar 

  20. Wong SK, Yu LM, Lau JY, Lam YH, Chan AC, Ng EK, et al. Prediction of therapeutic failure after adrenaline injection plus heat probe treatment in patients with bleeding peptic ulcer. Gut. 2002;50:322–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Lau JY, Wong KT, Chiu PW, Pittayanon R, Rerknimitr R, Holster IL, et al. Early angiographic embolization after endoscopic hemostasis to high risk bleeding peptic ulcers improves outcomes. Gastroenterology. 2014;146:S44.

    Google Scholar 

  22. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344, e3054.

    Article  PubMed Central  PubMed  Google Scholar 

  23. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;3777:1096–101.

    Google Scholar 

  24. Bennett C, Klingenberg SL, Langholz E, Gluud LL. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2014;11, CD006640. doi:10.1002/14651858.CD006640.pub3.

    PubMed  Google Scholar 

  25. Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, et al. HALT-IT tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomized controlled trial. Trials. 2014;15:450.

    Article  PubMed Central  PubMed  Google Scholar 

  26. El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000;95(12):3566–73.

    Article  CAS  PubMed  Google Scholar 

  27. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–9.

    Article  PubMed  Google Scholar 

  28. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5(3):419–24.

    Article  CAS  PubMed  Google Scholar 

  29. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248(6 Pt 1):G618–25.

    CAS  PubMed  Google Scholar 

  30. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol. 1985;1:325–37.

    Article  CAS  PubMed  Google Scholar 

  31. Conn HO, Ramsby GR, Storer EH, Mutchnick MG, Joshi PH, Phillips MM, et al. Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology. 1975;68(2):211–21.

    CAS  PubMed  Google Scholar 

  32. Mallory A, Schaefer JW, Cohen JR, Holt SA, Norton LW. Selective intra-arterial vasopression in fusion for upper gastrointestinal tract hemorrhage: a controlled trial. Arch Surg. 1980;115(1):30–2.

    Article  CAS  PubMed  Google Scholar 

  33. Bolognesi M, Balducci G, Garcia-Tsao G, et al. Complications in the medical treatment of portal hypertension. Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science; 2001. p. 180–203.

    Google Scholar 

  34. Gimson AE, Westaby D, Hegarty J, Watson A, Williams R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology. 1986;6(3):410–3.

    Article  CAS  PubMed  Google Scholar 

  35. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet. 1995;346(8979):865–8.

    Article  CAS  PubMed  Google Scholar 

  36. Ioannou GN, Doust J, Rockey DC. (2003) Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD002147. DOI: 10.1002/14651858.CD002147.

  37. Buonamico P, Sabbá C, Garcia-Tsao G, Berardi E, Antonica G, Ferraioli G, et al. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study. Hepatology. 1995;21(1):134–9.

    CAS  PubMed  Google Scholar 

  38. Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D’Heygere F, McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990;99(5):1388–95.

    CAS  PubMed  Google Scholar 

  39. Gøtzsche PC, Hróbjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev. 2008;3, CD000193. doi:10.1002/14651858.CD000193.pub3.

    PubMed  Google Scholar 

  40. Wells M, Chande N, Adams P, Beaton M, Levstik M, Boyce E, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35(11):1267–78. This meta-analysis demonstrated use of vasoactive agents as a group in acute variceal bleeding resulted in improved control of bleeding and decreased all cause mortality.

    Article  CAS  PubMed  Google Scholar 

  41. Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60(3):954–63. This multicenter non inferiority trial randomized variceal bleeders to pre endoscopic terlipressin, somatostatin and octreotide, and showed comparable hemostatic efficacy.

    Article  CAS  PubMed  Google Scholar 

  42. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1995;346(8979):865–8.

    Article  Google Scholar 

  43. Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet. 1995;346(8991–8992):1666–9.

    Article  CAS  PubMed  Google Scholar 

  44. Calès P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med. 2001;344(1):23–8.

    Article  PubMed  Google Scholar 

  45. Bañares R, Albillos A, Rincón D, Alonso S, González M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35(3):609–15.

    Article  PubMed  Google Scholar 

  46. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.

    Article  CAS  PubMed  Google Scholar 

  47. Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(9):727–38.

    Article  PubMed  Google Scholar 

  48. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding—an updated Cochrane review. Aliment Pharmacol Ther. 2011;34(5):509–18.

    Article  CAS  PubMed  Google Scholar 

  49. Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131(4):1049–56.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Kelvin L.Y. Lam declare that he have no conflict of interest.

John C. T. Wong declare that he have no conflict of interest.

James Y. W. Lau declare that he have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, 9th floor, Clinical Science Building, 30-32 Ngan Shing Street, Shatin, Hong Kong

    Kelvin L. Y. Lam MBBS & John C. T. Wong MD

  2. Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, 4th floor, Clinical Science Building, 30-32 Ngan Shing Street, Shatin, Hong Kong

    James Y. W. Lau MD

Authors
  1. Kelvin L. Y. Lam MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John C. T. Wong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Y. W. Lau MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Y. W. Lau MD.

Additional information

This article is part of the Topical Collection on Stomach

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lam, K.L.Y., Wong, J.C.T. & Lau, J.Y.W. Pharmacological Treatment in Upper Gastrointestinal Bleeding. Curr Treat Options Gastro 13, 369–376 (2015). https://doi.org/10.1007/s11938-015-0063-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-015-0063-x

Keywords

Search

Navigation